TrialThe oncologist2019

Endostatin and Oxaliplatin-Based Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Results of a Phase II Study.

Wenxin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.